Company

Remedy Pharmaceuticals, Inc.

Remedy Pharmaceuticals, Inc., based in New York, US, develops CIRARA, an investigational drug for acute ischemic stroke.

About

Founded in 2004 and based in New York, US, Remedy Pharmaceuticals develops therapeutics, mainly CIRARA, to aid neurological recovery in patients with acute ischemic stroke. In May 2017 Biogen, Inc. acquired the CIRARA asset for USD 120 mn. Founder David Geliebter has a history in the pharmaceutical industry. The company is at the Series B stage.

6Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in